Synapse

← Petar Seferović

Papers by Petar Seferović

Page 1 · newest first

  1. Heart Failure in Anthracycline Cardiotoxicity: From Mechanisms to Clinical Management.2026
  2. Great debate: diabetic cardiomyopathy is a distinct diseaseEuropean Heart Journal · 2026
  3. Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm SocietyEuropean Journal of Heart Failure · 2026
  4. Precipitants of Acute Heart Failure: A State-of-the-art Review from an International Expert GroupCardiac failure review · 2026
  5. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trialENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2022
  6. Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy RegistryEuropean Heart Journal · 2025
  7. Liver Function Abnormalities in Acute Heart Failure: A State-of-the-art Review from an International Expert GroupCardiac failure review · 2026
  8. A new and impactful ESC initiative: ESC Eastern Countries Task ForceEuropean Heart Journal · 2026
  9. The continuous heart failure spectrum: moving beyond an ejection fraction classificationEuropean Heart Journal · 2019
  10. Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey.2025
  11. SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAIESC Heart Failure · 2025
  12. The Right Approach: Power of Biomarkers in the Assessment and Management of Right Ventricular DysfunctionInternational Journal of Molecular Sciences · 2025
  13. Clinical care of family members of patients with dilated cardiomyopathyEuropean Heart Journal · 2025
  14. Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis—a narrative review: a joint session with the Romanian Society of Cardiology (part II)Heart Failure Reviews · 2025
  15. Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalitiesEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2025
  16. How to Facilitate Seamless Translation from Basic Concepts to New Heart Failure Drugs. A Scientific Statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2025
  17. The European Heart Failure Management Resources, Treatment Reimbursement and Activities of Professional and Patient OrganizationsEuropean Journal of Heart Failure · 2025
  18. Insights into the European Heart Failure EpidemiologyEuropean Journal of Heart Failure · 2025
  19. Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal · 2025
  20. Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure · 2025
  21. International expert agreement on World Scleroderma Foundation/Heart Failure Association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis–associated primary heart involvementJournal of Scleroderma and Related Disorders · 2025
  22. How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2025
  23. Clinical Management and Therapeutic Optimization of Patients with Heart Failure with Reduced Ejection Fraction and Low Blood Pressure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESCENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
  24. Assessment of Frailty in Patients with Heart Failure: A New Heart Failure Frailty Score Developed by Delphi ConsensusESC Heart Failure · 2025
  25. Safety and Efficacy of Echo- vs. Fluoroscopy-Guided Pericardiocentesis in Cardiac TamponadeMedicina · 2025
  26. Predischarge and Postdischarge Heart Failure Management: Treatment Optimisation, Adherence, and Multidisciplinary CareMedical Research Archives · 2025
  27. Metabolic Dysfunction: An Important Driver of Incident Heart Failure with Preserved and Reduced Ejection FractionEuropean Journal of Heart Failure · 2024
  28. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-1: Diagnostic and Therapeutic Challenges)Balkan Medical Journal · 2024
  29. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-2: Specific Entities, Risk Stratification and Challenges After Recovery)Balkan Medical Journal · 2024
  30. Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III RegistryEuropean Journal of Heart Failure · 2024
  31. Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registryEuropean Heart Journal · 2024
  32. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT.2024
  33. Patiromer-Facilitated Renin–Angiotensin–Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized TrialAmerican Journal of Nephrology · 2024
  34. Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of CardiologyEuropean Journal of Heart Failure · 2024
  35. Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyEuropean Journal of Heart Failure · 2024
  36. European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2024
  37. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial DiseasesEuropean Journal of Heart Failure · 2024
  38. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOTEuropean Journal of Preventive Cardiology · 2024
  39. Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESCEuropean Journal of Heart Failure · 2024
  40. Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)European Journal of Heart Failure · 2024
  41. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2024
  42. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryEuropean Heart Journal · 2024
  43. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular FunctionEuropean Journal of Heart Failure · 2024
  44. Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology PracticeEuropean Journal of Heart Failure · 2024
  45. Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)European Journal of Heart Failure · 2024
  46. Cardio‐renal‐metabolic disease in primary care settingDiabetes/Metabolism Research and Reviews · 2023
  47. Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyEuropean Journal of Preventive Cardiology · 2023
  48. The ‘Peptide for Life’ Initiative in the Emergency Department StudyESC Heart Failure · 2023
  49. Rationale and Design of the ESC Heart Failure III Registry – Implementation and DiscoveryEuropean Journal of Heart Failure · 2023
  50. Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registryENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2023